Loading...
•
Mar 31, 2024
Teladoc Q1 2024 Earnings Report
Reported a solid start to the year with strength in both revenue and adjusted EBITDA.
Key Takeaways
Teladoc Health reported a 3% year-over-year revenue increase to $646.1 million for Q1 2024. The company's net loss was $81.9 million, or $0.49 per share, while adjusted EBITDA increased by 20% year-over-year to $63.1 million.
Revenue grew 3% year-over-year to $646.1 million.
Net loss was $81.9 million, or $0.49 per share.
Adjusted EBITDA increased 20% year-over-year to $63.1 million.
Integrated Care segment revenue increased 8% while BetterHelp segment revenue decreased 4%.
Revenue by Segment
Revenue by Geographic Location
Forward Guidance
Teladoc Health provides an outlook based on current market conditions and expectations. For the second quarter of 2024, revenue is expected to be between $635 and $660 million, and adjusted EBITDA is expected to be between $70 and $80 million. For the full year of 2024, revenue is expected to be between $2,635 and $2,735 million, and adjusted EBITDA is expected to be between $350 and $390 million.
Positive Outlook
- Revenue between $635 - $660 million for Q2 2024
- Adjusted EBITDA between $70 - $80 million for Q2 2024
- U.S. Integrated Care Members between 92 - 93 million for Q2 2024
- Integrated Care Revenue growth percentage between 2.0% - 5.0% for Q2 2024
- Adjusted EBITDA between $350 - $390 million for full year 2024
Challenges Ahead
- Net loss per share (\$0.45) - (\$0.35) for Q2 2024
- BetterHelp Revenue growth percentage between (8.0%) - (4.0%) for Q2 2024
- Revenue between $2,635 - $2,735 million for full year 2024
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...